Kritika Rehani

Epilepsy market Epilepsy is a brain disorder, which is characterized by recurrent seizures. A seizure is defined as a sudden change of behaviour because of a temporary change in the electrical functioning in the brain. Usually, the brain continuously produces tiny electrical impulses in a pattern. The disease has many possible causes, and there are various types of seizures. Seizures can happen due to anything that interrupts the normal pattern of neuron activity from illness to brain damage to abnormal brain development. In patients having seizures, the normal electrical pattern is interrupted by sudden and synchronized bursts of electrical energy that may change their consciousness, movements, or sensations. The most epilepsy syndromes are more commonly found in males than in females. In the United States, around 3.4 million people live with epilepsy, and over 150,000 new cases are diagnosed with the disease each year. One in 26 people is likely to develop epilepsy at some

Breast Cancer Market shows promising trends About 1 in 8 U.S. women (about 12%) will develop invasive breast cancer over the course of her lifetime, according to Breast cancer organization. Moreover, the year 2019, an estimated 268,600 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S., along with 62,930 new cases of non-invasive (in situ) breast cancer. There are lots of risk factors that can cause Breast Cancer. Around 5-10% of the Breast cancer rates are hereditary and are caused by the transfer of abnormal genes to offspring. Most of the inherited cancers are caused due to the mutations in BRCA1 (BReast CAncer gene one) and BRCA2 (BReast CAncer gene two). Triple-negative breast cancer is a rare type of Breast cancer, affecting only about 10 to 20 percent of people with breast cancer . If a patient gets diagnose with Triple Negative Breast Cancer it certainly means the absence of expression of estrogen receptor (ER), progesterone recepto

Rising air pollution owing to increase in amount of harmful gasses like Chlorofluorocarbons, Carbon monoxide, Carbon dioxide, Nitrogen Oxide, Nitrogen dioxide and many more due to industrialization, increase in amount of vehicles, and other CFCs emitting appliances has caused in an increase in the number of respiratory diseases. Humans inhale theses toxic gasses and the result in damage in their air sacs and lungs. The increase in Respiratory problems has influenced the Therapeutic market of the respiratory disorders positively. DelveInsight, a Healthcare consulting company, observed that degradation in air quality has fuelled the market of air-borne disorders like Pneumonia, Acute respiratory distress syndrome (ARDS), Bronchitis, and many more. Acute respiratory distress syndrome (ARDS) is a severe form of lung condition characterized by excess fluid in the air sacs of lungs. This decrease the amount of oxygen in the bloodstream which ultimately causes failure of an organ. No

Hepatitis is the inflammation of the liver. The condition can be limited to self or can advance to scarring, cirrhosis or liver cancer. Hepatitis viruses are the most common origin of hepatitis in all over the world. Sometimes, other infections, toxic substances (e.g. alcohol, certain drugs), and autoimmune diseases can also cause hepatitis. There are five main hepatitis viruses, like types A, B, C, D and E. These five types are of the most significant concern. In particular, types B and C cause chronic disease in millions of people and are the cause of liver cirrhosis and cancer. Hepatitis A and E are characteristically caused due to contaminated food and water ingestion. Hepatitis B, C and D usually occur because of the result of parenteral contact with infected body fluids. Acute infection may arise with no or limited symptoms or may involve symptoms such as jaundice (yellowing of the skin and eyes), dark-coloured urine, extreme fatigue, nausea, barfing and feel abdominal

A  rare disease  is a disease that affects a tiny percentage of the population. In other words, an  orphan disease  is a rare disease, which means that there is a shortage of a market to get support and resources for discovering treatments for it. Most rare diseases are genetic and affect throughout the person's life, although symptoms do not become immediately visible. There are various causes of rare diseases. The majority of them are directly caused a change in genes or chromosomes and are passed from one generation to the next.  Most of the rare diseases appear early in life, and about 30% of children with these diseases will die after five years of birth. There may be as many as 7,000 rare diseases. Only a few types of rare diseases are diagnosed in the United States. The Americans are living with a rare disease and are estimated at between 25-30 million. In recent years, rare-disease products have intrigued pharmaceutical and biotech companies and firms. While

The Healthcare companies invest almost a decade or more in developing a drug. The research phase and then tiresome clinical trials consume over a decade then they undergo commercialization, marketing, financial management and patent issues. To overcome all of these problems, Healthcare domain need consulting services that can help them sustain the Healthcare market. Healthcare consulting companies help healthcare firms to identify promising areas which are untouched and can bear optimistic outputs. Healthcare consulting companies help life science and biotech companies by providing them with valuable insights in market trends of specific indications and overall healthcare domain. Healthcare industry reports are categorized on the basis of therapeutic areas and the report type. DelveInsight, a leading healthcare consulting company, is known for providing elucidated healthcare market reports on more than 27 therapeutic areas. The vast repository of DelveInsight armed with 5000

Non-alcoholic fatty liver disease  (NAFLD), is the most common cluster of conditions observed in in the population of younger age. The rising NAFLD prevalence worldwide, attributed to rising complications associated with insulin resistance, obesity and other metabolic disorders results in severe liver damage resulting in Non-alcoholic steatohepatitis (NASH). NASH is an accumulation of fat in the liver in an enormous amount in the people whose intake of alcohol is nil or minimal. This build-up with time starts to damage cells and inflammation of the liver rendering liver non-functional arising the situation of liver transplant. NASH has become a serious problem now. According to a Healthcare Consulting company, DelveInsight, the increase in Diabetes prevalence and rising trends of obesity among people, NAFLD prevalent cases are set to hike at a CAGR rate of 1.02% for the study period 2016-27 in the 7MM. Furthermore, highest NASH prevalence is observed in the United States, wh

  Dermatology is the specialized branch of medicine targeting the skin and treatment of skin-related diseases and conditions. This covers a variety of conditions, both pathological and cosmetic. Derma market products include medicine and products that are used daily like lotions, soft gels, shampoos, creams, etc. So, here, the dermatology industry kicks in to stop and treat skin issues. Dermatology market is a vast sector that deals in various segments as the dermatology disorders vary throughout the world based on Geographic location, Climatic conditions, Socioeconomic status, Lifestyles, Age, Gender, Heredity, and Personal habits. Dermatology industry is increasing all over the world. It is one of the largest markets of the pharmaceuticals industry. Dermatology market is a highly specialized, niche segment in the global pharmaceutical industry.  The need for skincare products is increasing day by day [WU1]   across the world. This industry includes drugs to treat diseases such

Pharmaceutical Consulting is the process of assisting the companies involved in research, production, and commercialization of medicinal drugs or medical devices. With the ever-changing pharma landscape, there is a dire need for business solutions and optimization to stay ahead in the competition. That is where the role of pharma consulting companies comes into play; to help pharmaceutical companies in taking their business forward. A consultant in the pharmaceutical industry has the expertise and reliable knowledge, who can provide companies with relevant information and advice to a problematic situation. Pharmaceutical industries partners with consulting companies, for improving their business and solving their day-to-day challenges. Pharma consulting companies provide solutions in business problems related to pharma market assessment, clinical trials, regulatory analysis, partner identification, asset prioritization, drug commercialization, and drug marketing, pharmaceutical

Consulting Company  A consulting company is a company that dedicatedly render consulting, advisory services and un-biased feedback to any organization or any individual. Consulting companies target specific industries and deliver solutions to various sorts of issues faced by different companies. A steep rise in tertiary sector has given rise to a separate new industry in the tertiary sector, Pharma and Biotech consulting services. The last decade saw the emergence of 10 of the largest consulting firms with revenue worth 170 Million dollars and an average annual growth rate of 4%. Not even a single industry is left where consulting firms have not left their mark. From IT to Financial services, from Healthcare to Accounting, subject-matter experts and consultants proffer advisory services to them for effective business decision-making. Biotech Consulting Firms in Biotechnology A magnificent hike in the number of pharmaceutical and healthcare companies has exemplified the